According to the Michael J. Fox Foundation, approximately 10-20% of people with Parkinson’s disease experience symptoms before age 50. This is known as early- or young-onset Parkinson’s disease. There are distinct genetic and clinical differences between young-onset and idiopathic (late-onset) Parkinson’s disease. It’s important for healthcare providers to be aware of and understand these differences, as this will help reduce the number of misdiagnosed or undiagnosed cases of young-onset Parkinson’s disease.
In this article, we will provide an overview of young-onset Parkinson’s disease, highlight the key differences between young-onset and idiopathic Parkinson’s, and discuss the importance of receiving an early, accurate young-onset Parkinson’s disease diagnosis.
People living with young-onset Parkinson’s disease experience similar symptoms as those living with idiopathic Parkinson’s disease. This includes motor-related symptoms, such as:
People living with young-onset Parkinson’s disease may also experience non-motor-related symptoms, such as:
Like idiopathic Parkinson’s disease, young-onset Parkinson’s is diagnosed “clinically”, meaning diagnosis is dependent on medical history, answers to certain questions, physical examination, and the presence of specific physical symptoms. Because Parkinson’s disease is less common in young adults, the path to diagnosis is often lengthy. Treatment of young-onset Parkison’s disease is similar to that of idiopathic Parkinson’s disease.
Experts currently believe that young-onset Parkinson’s disease manifests itself differently than idiopathic Parkinson’s disease. Young-onset Parkinson’s disease is associated with different symptom characteristics and different rates of disease progression. Additionally, the development of young-onset Parkinson’s disease is believed to be more likely to be related to genetics compared to idiopathic Parkinson’s disease. Certain genetic mutations, such as in the SNCA, PRKN, PARK7, and PINK1 genes, have been linked to an increased risk of young-onset Parkinson’s disease.
The symptoms and rate of disease progression are often different in young-onset Parkinson’s disease. In general, the disease continuum for young-onset Parkison’s disease spans a longer period of time. People living with young-onset Parkinson’s disease usually remain cognitively and functionally intact for a longer period of time. Additionally, they may experience more side effects from dopaminergic, or dopamine-producing, medications, such as more frequent dyskinesias (involuntary movements).
In people living with young-onset Parkinson’s disease, the onset of symptoms typically occurs between 21 and 40 years of age—yet only 2% of people diagnosed with Parkinson’s disease are diagnosed before age 40. Misdiagnosis, or lack of diagnosis, of young-onset Parkinson’s disease is common. Because young-onset Parkinson’s disease manifests itself differently and may require slightly different treatment and management approaches, receiving an early and accurate diagnosis of young-onset Parkinson’s is essential for receiving precise, personalized treatment and care. Additionally, younger individuals with Parkinson’s disease are often better candidates for certain surgical and medical interventions.
Parkinson’s disease, while a chronic condition, can be well managed—but this is often dependent on receiving an early and accurate diagnosis. This is particularly important for people living with young-onset Parkinson’s disease, as, at this stage in their life, they may be raising children, working on advancing their careers, or even starting a new chapter of their lives.
Altoida’s mission is to accelerate and improve drug development, neurological disease research, and patient care. To learn more about our precision-neurology platform and app-based medical device, contact us!